"10.1371_journal.pone.0100452","plos one","2014-06-25T00:00:00Z","Jennifer Papuchon; Patricia Pinson; Gwenda-Line Guidicelli; Pantxika Bellecave; Réjean Thomas; Roger LeBlanc; Sandrine Reigadas; Jean-Luc Taupin; Jean Guy Baril; Jean Pierre Routy; Mark Wainberg; Hervé Fleury; the Provir/Latitude 45 study group","University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France; University Hospital of Bordeaux and CNRS UMR 5164, Bordeaux, France; Clinique médicale l'Actuel, Montréal, Canada; Clinique médicale Opus, Montréal, Canada; Clinique Médicale du Quartier Latin, Montréal, Canada; McGill University Health Centre, Montréal, Canada; McGill AIDS Centre, Montréal, Canada","Conceived and designed the experiments: HF. Performed the experiments: JP PP GG SR. Analyzed the data: JP PP GG SR JLT JGB JPR MW HF. Contributed reagents/materials/analysis tools: GG JLT RT RL JGB JPR MW HF. Wrote the paper: JP PP GG PB SR JGB JPR MW HF.","This study was funded by Merck. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","06","Jennifer Papuchon","JP",13,TRUE,1,4,9,9,TRUE,TRUE,TRUE,1,"13",TRUE
